Five Oceans Advisors’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.24M Hold
7,908
0.4% 35
2026
Q1
$1.21M Hold
7,908
0.44% 30
2025
Q4
$1.09M Hold
7,908
0.39% 32
2025
Q3
$1.01M Hold
7,908
0.37% 35
2025
Q2
$957K Buy
7,908
+565
+8% +$63.7K 0.41% 37
2025
Q1
$819K Buy
7,343
+2,087
+40% +$222K 0.39% 41
2024
Q4
$511K Sell
5,256
-5,037
-49% -$537K 0.23% 63
2024
Q3
$1.18M Buy
10,293
+3,806
+59% +$432K 0.57% 31
2024
Q2
$691K Buy
6,487
+941
+17% +$94.5K 0.36% 48
2024
Q1
$536K Hold
5,546
0.28% 58
2023
Q4
$560K Hold
5,546
0.31% 60
2023
Q3
$565K Hold
5,546
0.36% 57
2023
Q2
$560K Hold
5,546
0.36% 57
2023
Q1
$510K Sell
5,546
-2,040
-27% -$178K 0.33% 70
2022
Q4
$688K Hold
7,586
0.48% 45
2022
Q3
$577K Buy
7,586
+3,382
+80% +$280K 0.46% 52
2022
Q2
$355K Buy
4,204
+807
+24% +$70.8K 0.26% 76
2022
Q1
$298K Buy
3,397
+1,083
+47% +$93.8K 0.27% 74
2021
Q4
$202K Sell
2,314
-156
-6% -$13K 0.18% 107
2021
Q3
$202K Buy
+2,470
New +$222K 0.23% 90

Other funds holding NVS

Five Oceans Advisors's NVS Position: Q2 2026 in Review

Five Oceans Advisors held its Novartis (NVS) position steady in Q2 2026 at 7,908 shares worth $1.24M. The position accounts for 0.4% of the portfolio, ranked #35.

Five Oceans Advisors first reported a position in NVS in Q3 2021 and has held it in 20 quarters since. 285 funds tracked by Wall St. Rank hold NVS as of Q2 2026.

  • Five Oceans Advisors held 7,908 shares of Novartis worth $1.24M as of Q2 2026.
  • Five Oceans Advisors left its Novartis share count unchanged in Q2 2026.
  • Novartis made up 0.4% of Five Oceans Advisors's portfolio in Q2 2026, its #35 holding.
  • Five Oceans Advisors first reported a position in Novartis in Q3 2021 and has held it in 20 quarters since.
  • 285 funds tracked by Wall St. Rank held Novartis as of Q2 2026.

Based on Five Oceans Advisors's 13F filing for Q2 2026, filed 15 Jul 2026.